Found 6 results
Author Title Type [ Year(Asc)]
Filters: Author is Tartaglia, J  [Clear All Filters]
2009
S. Rerks-Ngarm, Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., Benenson, M., Gurunathan, S., Tartaglia, J., McNeil, J., Francis, D., Stablein, D., Birx, D., Chunsuttiwat, S., and Khamboonruang, C., “Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand”, N Engl J Med, vol. 361, pp. 2209-2220, 2009.
2000
R. Bures, Gaitan, A., Zhu, T., Graziosi, C., McGrath, K. M., Tartaglia, J., Caudrelier, P., R Habib, E., Klein, M., Lazzarin, A., Stablein, D. M., Deers, M., Corey, L., Greenberg, M. L., Schwartz, D. H., and Montefiore, D. C., “Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus Type 1”, AIDS Res HumRetroviruses, vol. 16, pp. 2019-35, 2000.
R. Bures, Gaitan, A., Zhu, T., Graziosi, C., McGrath, K. M., Tartaglia, J., Caudrelier, P., R Habib, E., Klein, M., Lazzarin, A., Stablein, D. M., Deers, M., Corey, L., Greenberg, M. L., Schwartz, D. H., and Montefiori, D. C., “Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1.”, AIDS Res Hum Retroviruses, vol. 16, no. 18, pp. 2019-35, 2000.
1999
T. G. Evans, Keefer, M. C., Weinhold, K. J., Wolff, M., Montefiori, D., Gorse, G. J., Graham, B. S., McElrath, M. J., Clements-Mann, M. L., Mulligan, M. J., Fast, P., Walker, M. C., Excler, J. L., Duliege, A. M., Tartaglia, J., and Group, theN. I. A. I. D. A. I. D. S., “A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers”, J Infec Dis, vol. 180, pp. 290-8, 1999.
T. G. Evans, Keefer, M. C., Weinhold, K. J., Wolff, M., Montefiori, D., Gorse, G. J., Graham, B. S., McElrath, M. J., Clements-Mann, M. L., Mulligan, M. J., Fast, P., Walker, M. C., Excler, J. L., Duliege, A. M., and Tartaglia, J., “A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers.”, J Infect Dis, vol. 180, no. 2, pp. 290-8, 1999.
1998
M. L. Clements-Mann, Weinhold, K., Matthews, T. J., Graham, B. S., Gorse, G. J., Keefer, M. C., McElrath, M. J., Hsieh, R. H., Mestecky, J., Zolla-Pazner, S., Mascola, J., Schwartz, D., Siliciano, R., Corey, L., Wright, P. F., Belshe, R., Dolin, R., Jackson, S., Xu, S., Fast, P., Walker, M. C., Stablein, D., Excler, J. L., Tartaglia, J., and Paoletti, E., “Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group.”, J Infect Dis, vol. 177, no. 5, pp. 1230-46, 1998.